Molecular pathogenesis of hepatic fibrosis and current therapeutic approaches

Chemico-Biological Interactions

Volumn 193, Issue 3, 2011, Pages 225-231

  Mormone, Elisabetta ^a   George, Joseph ^a   Nieto, Natalia ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Collagen; Extracellular matrix; Liver injury; Stellate cells

Indexed keywords

5 NITROSO N ACETYLCYSTEINE; ACETALDEHYDE; ACETYLCYSTEINE; ALCOHOL; ALPHA SMOOTH MUSCLE ACTIN; ALPHA TOCOPHEROL; ANTIOXIDANT; ANTISENSE OLIGONUCLEOTIDE; ANTIVIRUS AGENT; COLCHICINE; COLLAGEN; COLLAGEN TYPE 1; CORTICOSTEROID; CURCUMIN; GENISTEIN; HEPATITIS B VACCINE; INTERLEUKIN 10; MALOTILATE; MATRIX METALLOPROTEINASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; PHOSPHATIDYLCHOLINE; PROTEOGLYCAN; RIBAVIRIN; RIBOZYME; S ADENOSYLMETHIONINE; SILYMARIN; SMALL INTERFERING RNA; TISSUE INHIBITOR OF METALLOPROTEINASE; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ALCOHOL CONSUMPTION; AUTOIMMUNE HEPATITIS; BILIARY TRACT DISEASE; CELL ACTIVATION; CELL TRANSFORMATION; DRUG ACTIVITY; DRUG TARGETING; ENDOTHELIUM CELL; FIBROGENESIS; HEPATITIS B; HEPATITIS C; HUMAN; LIVER CELL CARCINOMA; LIVER FIBROSIS; LIVER TOXICITY; MESENCHYMAL STEM CELL; METABOLIC DISORDER; MYOFIBROBLAST; NONHUMAN; OBESITY; OXIDATIVE STRESS; PATHOGENESIS; PORTAL HYPERTENSION; PROTEIN EXPRESSION; REVIEW; STELLATE CELL; UPREGULATION; WOUND HEALING;

EID: 80052707667     PISSN: 00092797     EISSN: 18727786     Source Type: Journal    
DOI: 10.1016/j.cbi.2011.07.001     Document Type: Article

References (104)

1. D. Schuppan Structure of the extracellular matrix in normal and fibrotic liver: Collagens and glycoproteins Semin. Liver Dis. 10 1 1990 1 10 (Pubitemid 20163701)
2. P.P. Anthony, K.G. Ishak, N.C. Nayak, H.E. Poulsen, P.J. Scheuer, and L.H. Sobin The morphology of cirrhosis. Recommendations on definition, nomenclature, and classification by a working group sponsored by the World Health Organization J. Clin. Pathol. 31 5 1978 395 414 (Pubitemid 8333033)
3. S.L. Friedman Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury J. Biol. Chem. 275 4 2000 2247 2250 (Pubitemid 30081976)
4. J. George, K.R. Rao, R. Stern, and G. Chandrakasan Dimethylnitrosamine- induced liver injury in rats: The early deposition of collagen Toxicology 156 2-3 2001 129 138 (Pubitemid 32119485)
5. D.M. Bissell Cell-matrix interaction and hepatic fibrosis Prog. Liver Dis. 9 1990 143 155
6. J. George, and G. Chandrakasan Biochemical abnormalities during the progression of hepatic fibrosis induced by dimethylnitrosamine Clin. Biochem. 33 7 2000 563 570 (Pubitemid 32012440)
7. Y.P. Han, L. Zhou, J. Wang, S. Xiong, W.L. Garner, S.W. French, and H. Tsukamoto Essential role of matrix metalloproteinases in interleukin-1-induced myofibroblastic activation of hepatic stellate cell in collagen J. Biol. Chem. 279 6 2004 4820 4828 (Pubitemid 38199077)
8. A.M. Miller, N. Horiguchi, W.I. Jeong, S. Radaeva, and B. Gao Molecular mechanisms of alcoholic liver disease: Innate immunity and cytokines Alcohol. Clin. Exp. Res. 35 5 2011 787 793
9. F.A. Anania, J.J. Potter, L. Rennie-Tankersley, and E. Mezey Activation by acetaldehyde of the promoter of the mouse alpha2(I) collagen gene when transfected into rat activated stellate cells Arch. Biochem. Biophys. 331 2 1996 187 193 (Pubitemid 26256066)
10. A. Chen Acetaldehyde stimulates the activation of latent transforming growth factor-beta1 and induces expression of the type II receptor of the cytokine in rat cultured hepatic stellate cells Biochem. J. 368 Pt 3 2002 683 693 (Pubitemid 36042670)
11. G. Svegliati-Baroni, Y. Inagaki, A.R. Rincon-Sanchez, C. Else, S. Saccomanno, A. Benedetti, F. Ramirez, and M. Rojkind Early response of alpha2(I) collagen to acetaldehyde in human hepatic stellate cells is TGF-beta independent Hepatology 42 2 2005 343 352 (Pubitemid 41061087)
12. H.L. Weng, Y. Liu, J.L. Chen, T. Huang, L.J. Xu, P. Godoy, J.H. Hu, C. Zhou, F. Stickel, A. Marx, R.M. Bohle, V. Zimmer, F. Lammert, S. Mueller, M. Gigou, D. Samuel, P.R. Mertens, M.V. Singer, H.K. Seitz, and S. Dooley The etiology of liver damage imparts cytokines transforming growth factor beta1 or interleukin-13 as driving forces in fibrogenesis Hepatology 50 1 2009 230 243
13. P. Greenwel, J.A. Dominguez-Rosales, G. Mavi, A.M. Rivas-Estilla, and M. Rojkind Hydrogen peroxide: A link between acetaldehyde-elicited alpha1(I) collagen gene up-regulation and oxidative stress in mouse hepatic stellate cells Hepatology 31 1 2000 109 116 (Pubitemid 30033696)
14. F. Stickel, R. Urbaschek, D. Schuppan, G. Poeschl, C. Oesterling, C. Conradt, R.S. McCuskey, U.A. Simanowski, and H.K. Seitz Serum collagen type VI and XIV and hyaluronic acid as early indicators for altered connective tissue turnover in alcoholic liver disease Digest. Dis. Sci. 46 9 2001 2025 2032 (Pubitemid 32844173)
15. M. Parola, and G. Robino Oxidative stress-related molecules and liver fibrosis J. Hepatol. 35 2 2001 297 306 (Pubitemid 32803489)
16. J. Haorah, S.H. Ramirez, N. Floreani, S. Gorantla, B. Morsey, and Y. Persidsky Mechanism of alcohol-induced oxidative stress and neuronal injury Free Radic. Biol. Med. 45 11 2008 1542 1550
17. A.I. Cederbaum Hepatoprotective effects of S-adenosyl-L-methionine against alcohol- and cytochrome P450 2E1-induced liver injury World J. Gastroenterol. 16 11 2010 1366 1376
18. R. Bataller, and D.A. Brenner Liver fibrosis J. Clin. Invest. 115 2 2005 209 218 (Pubitemid 40385459)
19. B. Custer, S.D. Sullivan, T.K. Hazlet, U. Iloeje, D.L. Veenstra, and K.V. Kowdley Global epidemiology of hepatitis B virus J. Clin. Gastroenterol. 38 10 2004 S158 S168
20. K. Das, P.S. Mukherjee, A. Ghosh, S. Ghosh, A.R. Mridha, T. Dhibar, B. Bhattacharya, D. Bhattacharya, B. Manna, G.K. Dhali, A. Santra, and A. Chowdhury Nonobese population in a developing country has a high prevalence of nonalcoholic fatty liver and significant liver disease Hepatology 51 5 2010 1593 1602
21. Y.S. Lim, H.B. Oh, S.E. Choi, O.J. Kwon, Y.S. Heo, H.C. Lee, and D.J. Suh Susceptibility to type 1 autoimmune hepatitis is associated with shared amino acid sequences at positions 70-74 of the HLA-DRB1 molecule J. Hepatol. 48 1 2008 133 139 (Pubitemid 350191994)
22. K.L. Andersson, and R.T. Chung Hepatic schistosomiasis Curr. Treat. Options Gastroenterol. 10 6 2007 504 512 (Pubitemid 350284933)
23. J.H. Lefkowitch Hepatobiliary pathology Curr. Opin. Gastroenterol. 22 3 2006 198 208 (Pubitemid 44090055)
24. J.N. Feder, A. Gnirke, W. Thomas, Z. Tsuchihashi, D.A. Ruddy, and A. Basava The discovery of the new haemochromatosis gene. 1996 J. Hepatol. 38 6 2003 704 709
25. S. Zhang, S. Chen, W. Li, X. Guo, P. Zhao, J. Xu, Y. Chen, Q. Pan, X. Liu, D. Zychlinski, H. Lu, M.D. Tortorella, A. Schambach, Y. Wang, D. Pei, M.A. Esteban, Rescue of ATP7B function in hepatocyte-like cells from Wilson's disease induced pluripotent stem cells using gene therapy or the chaperone drug curcumin, Hum. Mol. Genet. (2011).
26. J. George, and M. Tsutsumi SiRNA-mediated knockdown of connective tissue growth factor prevents N-nitrosodimethylamine-induced hepatic fibrosis in rats Gene Ther. 14 10 2007 790 803 (Pubitemid 46706059)
27. M. Domenicali, P. Caraceni, F. Giannone, M. Baldassarre, G. Lucchetti, C. Quarta, C. Patti, L. Catani, C. Nanni, R.M. Lemoli, and M. Bernardi A novel model of CCl4-induced cirrhosis with ascites in the mouse J. Hepatol. 51 6 2009 991 999
28. R. Salguero Palacios, M. Roderfeld, S. Hemmann, T. Rath, S. Atanasova, A. Tschuschner, O.A. Gressner, R. Weiskirchen, J. Graf, and E. Roeb Activation of hepatic stellate cells is associated with cytokine expression in thioacetamide-induced hepatic fibrosis in mice Lab. Invest. 88 11 2008 1192 1203
29. S.L. Friedman Mechanisms of hepatic fibrogenesis Gastroenterology 134 6 2008 1655 1669 (Pubitemid 351615417)
30. A.M. Gressner Transdifferentiation of hepatic stellate cells (Ito cells) to myofibroblasts: A key event in hepatic fibrogenesis Kidney Int. 49 1996 S39 S45 (Pubitemid 26155479)
31. N. Nieto, S.L. Friedman, and A.I. Cederbaum Cytochrome P450 2E1-derived reactive oxygen species mediate paracrine stimulation of collagen I protein synthesis by hepatic stellate cells J. Biol. Chem. 277 12 2002 9853 9864 (Pubitemid 34968090)
32. N. Nieto Oxidative-stress and IL-6 mediate the fibrogenic effects of rodent Kupffer cells on stellate cells Hepatology 44 6 2006 1487 1501 (Pubitemid 44953654)
33. H. Tsukamoto Cytokine regulation of hepatic stellate cells in liver fibrosis Alcohol. Clin. Exp. Res. 23 5 1999 911 916 (Pubitemid 29256581)
34. F.J. Cubero, and N. Nieto Ethanol and arachidonic acid synergize to activate kupffer cells and modulate the fibrogenic response via tumor necrosis factor alpha, reduced glutathione, and transforming growth factor beta-dependent mechanisms Hepatology 48 6 2008 2027 2039
35. E. Seki, and D.A. Brenner Toll-like receptors and adaptor molecules in liver disease: Update Hepatology 48 1 2008 322 335 (Pubitemid 351975556)
36. B. Gao, E. Seki, D.A. Brenner, S. Friedman, J.I. Cohen, L. Nagy, G. Szabo, and S. Zakhari Innate immunity in alcoholic liver disease Am. J. Physiol. Gastrointest. Liver Physiol. 300 4 2011 G516 525
37. B. Tuchweber, A. Desmouliere, M.L. BochatonPiallat, L. RubbiaBrandt, and G. Gabbiani Proliferation and phenotypic modulation of portal fibroblasts in the early stages of cholestatic fibrosis in the rat Lab. Invest. 74 1 1996 265 278 (Pubitemid 26041028)
38. Z. Li, J.A. Dranoff, E.P. Chan, M. Uemura, J. Sevigny, and R.G. Wells Transforming growth factor-beta and substrate stiffness regulate portal fibroblast activation in culture Hepatology 46 4 2007 1246 1256 (Pubitemid 350144789)
39. A. Desmouliere, I. Darby, A.M. Costa, M. Raccurt, B. Tuchweber, P. Sommer, and G. Gabbiani Extracellular matrix deposition, lysyl oxidase expression, and myofibroblastic differentiation during the initial stages of cholestatic fibrosis in the rat Lab. Invest. 76 6 1997 765 778 (Pubitemid 27260344)
40. Z. Gao, V.C. McAlister, and G.M. Williams Repopulation of liver endothelium by bone-marrow-derived cells Lancet 357 9260 2001 932 933 (Pubitemid 32247285)
41. H. Fujii, T. Hirose, S. Oe, K. Yasuchika, H. Azuma, T. Fujikawa, M. Nagao, and Y. Yamaoka Contribution of bone marrow cells to liver regeneration after partial hepatectomy in mice J. Hepatol. 36 5 2002 653 659 (Pubitemid 34499403)
42. Y.J. Chang, J.W. Liu, P.C. Lin, L.Y. Sun, C.W. Peng, G.H. Luo, T.M. Chen, R.P. Lee, S.Z. Lin, H.J. Harn, and T.W. Chiou Mesenchymal stem cells facilitate recovery from chemically induced liver damage and decrease liver fibrosis Life Sci. 85 13-14 2009 517 525
43. R. Higashiyama, Y. Inagaki, Y.Y. Hong, M. Kushida, S. Nakao, M. Niioka, T. Watanabe, H. Okano, Y. Matsuzaki, G. Shiota, and I. Okazaki Bone marrow-derived cells express matrix metalloproteinases and contribute to regression of liver fibrosis in mice Hepatology 45 1 2007 213 222 (Pubitemid 46144381)
44. T.G. Bird, S. Lorenzini, and S.J. Forbes Activation of stem cells in hepatic diseases Cell Tissue Res. 331 1 2008 283 300 (Pubitemid 50005924)
45. S.J. Forbes, F.P. Russo, V. Rey, P. Burra, M. Rugge, N.A. Wright, and M.R. Alison A significant proportion of myofibroblasts are of bone marrow origin in human liver fibrosis Gastroenterology 126 4 2004 955 963 (Pubitemid 38451166)
46. S. Dooley, J. Hamzavi, L. Ciuclan, P. Godoy, I. Ilkavets, S. Ehnert, E. Ueberham, R. Gebhardt, S. Kanzler, A. Geier, K. Breitkopf, H. Weng, and P.R. Mertens Hepatocyte-specific Smad7 expression attenuates TGF-beta-mediated fibrogenesis and protects against liver damage Gastroenterology 135 2 2008 642 659
47. T. Nitta, J.S. Kim, D. Mohuczy, and K.E. Behrns Murine cirrhosis induces hepatocyte epithelial mesenchymal transition and alterations in survival signaling pathways Hepatology 48 3 2008 909 919
48. R.G. Wells The epithelial-to-mesenchymal transition in liver fibrosis: Here today, gone tomorrow? Hepatology 51 3 2010 737 740
49. T. Kisseleva, and D.A. Brenner Is it the end of the line for the EMT? Hepatology 53 5 2011 1433 1435
50. M. Zeisberg, C. Yang, M. Martino, M.B. Duncan, F. Rieder, H. Tanjore, and R. Kalluri Fibroblasts derive from hepatocytes in liver fibrosis via epithelial to mesenchymal transition J. Biol. Chem. 282 32 2007 23337 23347 (Pubitemid 47311952)
51. A. Kaimori, J. Potter, J.Y. Kaimori, C. Wang, E. Mezey, and A. Koteish Transforming growth factor-beta1 induces an epithelial-to-mesenchymal transition state in mouse hepatocytes in vitro J. Biol. Chem. 282 30 2007 22089 22101 (Pubitemid 47195788)
52. K. Taura, K. Miura, K. Iwaisako, C.H. Osterreicher, Y. Kodama, M. Penz-Osterreicher, and D.A. Brenner Hepatocytes do not undergo epithelial-mesenchymal transition in liver fibrosis in mice Hepatology 51 3 2010 1027 1036
53. D. Scholten, C.H. Osterreicher, A. Scholten, K. Iwaisako, G. Gu, D.A. Brenner, and T. Kisseleva Genetic labeling does not detect epithelial-to- mesenchymal transition of cholangiocytes in liver fibrosis in mice Gastroenterology 139 3 2010 987 998
54. H. Robertson, J.A. Kirby, W.W. Yip, D.E.J. Jones, and A.D. Burt Biliary epithelial-mesenchymal transition in posttransplantation recurrence of primary biliary cirrhosis Hepatology 45 4 2007 977 981 (Pubitemid 46631566)
55. K.A. Rygiel, H. Robertson, H.L. Marshall, M. Pekalski, L. Zhao, T.A. Booth, D.E. Jones, A.D. Burt, and J.A. Kirby Epithelial-mesenchymal transition contributes to portal tract fibrogenesis during human chronic liver disease Lab. Invest. 88 2 2008 112 123 (Pubitemid 351161272)
56. R. Bucala, L.A. Spiegel, J. Chesney, M. Hogan, and A. Cerami Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair Mol. Med. 1 1 1994 71 81
57. B.B. Moore, J.E. Kolodsick, V.J. Thannickal, K. Cooke, T.A. Moore, C. Hogaboam, C.A. Wilke, and G.B. Toews CCR2-mediated recruitment of fibrocytes to the alveolar space after fibrotic injury Am. J. Pathol. 166 3 2005 675 684 (Pubitemid 40315625)
58. T. Kisseleva, H. Uchinami, N. Feirt, O. Quintana-Bustamante, J.C. Segovia, R.F. Schwabe, and D.A. Brenner Bone marrow-derived fibrocytes participate in pathogenesis of liver fibrosis J. Hepatol. 45 3 2006 429 438 (Pubitemid 44142115)
59. F.P. Russo, M.R. Alison, B.W. Bigger, E. Amofah, A. Florou, F. Amin, G. Bou-Gharios, R. Jeffery, J.P. Iredale, and S.J. Forbes The bone marrow functionally contributes to liver fibrosis Gastroenterology 130 6 2006 1807 1821 (Pubitemid 43668827)
60. M. Roderfeld, T. Rath, R. Voswinckel, C. Dierkes, H. Dietrich, D. Zahner, J. Graf, and E. Roeb Bone marrow transplantation demonstrates medullar origin of CD34(+) fibrocytes and ameliorates hepatic fibrosis in abcb4(-/-) mice Hepatology 51 1 2010 267 276
61. V. Hernandez-Gea, and S.L. Friedman Pathogenesis of liver fibrosis Annu. Rev. Pathol. 6 2011 425 456
62. M. Zeisberg, K. Kramer, N. Sindhi, P. Sarkar, M. Upton, and R. Kalluri De-differentiation of primary human hepatocytes depends on the composition of specialized liver basement membrane Mol. Cell. Biochem. 283 1-2 2006 181 189
63. J. George, and G. Chandrakasan Glycoprotein metabolism in dimethylnitrosamine induced hepatic fibrosis in rats Int. J. Biochem. Cell Biol. 28 3 1996 353 361 (Pubitemid 26116667)
64. J. George, M. Tsutsumi, and S. Takase Expression of hyaluronic acid in N-nitrosodimethylamine induced hepatic fibrosis in rat Int. J. Biochem. Cell Biol. 36 2 2004 307 319 (Pubitemid 37487765)
65. N. Nieto, S.L. Friedman, and A.I. Cederbaum Stimulation and proliferation of primary rat hepatic stellate cells by cytochrome P450 2E1-derived reactive oxygen species Hepatology 35 1 2002 62 73 (Pubitemid 34032544)
66. P. Muriel Role of free radicals in liver diseases Hepatol. Int. 3 4 2009 526 536
67. H. Tilg, and G.S. Hotamisligil Nonalcoholic fatty liver disease: Cytokine-adipokine interplay and regulation of insulin resistance Gastroenterology 131 3 2006 934 945 (Pubitemid 44307061)
68. S. De Minicis, R. Bataller, and D.A. Brenner NADPH oxidase in the liver: Defensive, offensive, or fibrogenic? Gastroenterology 131 1 2006 272 275
69. J. George Ascorbic acid concentrations in dimethylnitrosamine-induced hepatic fibrosis in rats Clin. Chim. Acta 335 1-2 2003 39 47 (Pubitemid 37338306)
70. T. Goto, K.I. Mikami, K. Miura, S. Ohshima, K. Yoneyama, K. Nakane, D. Watanabe, M. Otaka, and S. Watanabe Mechanical stretch induces matrix metalloproteinase 1 production in human hepatic stellate cells Pathophysiology 11 3 2004 153 158 (Pubitemid 39550761)
71. J.P. Iredale, S. Goddard, G. Murphy, R.C. Benyon, and M.J. Arthur Tissue inhibitor of metalloproteinase-I and interstitial collagenase expression in autoimmune chronic active hepatitis and activated human hepatic lipocytes Clin. Sci. (Lond.) 89 1 1995 75 81
72. T. Knittel, M. Mehde, A. Grundmann, B. Saile, J.G. Scharf, and G. Ramadori Expression of matrix metalloproteinases and their inhibitors during hepatic tissue repair in the rat Histochem. Cell Biol. 113 6 2000 443 453 (Pubitemid 30436163)
73. R.C. Benyon, and M.J. Arthur Extracellular matrix degradation and the role of hepatic stellate cells Semin. Liver Dis. 21 3 2001 373 384 (Pubitemid 32923766)
74. J.P. Iredale, R.C. Benyon, M.J. Arthur, W.F. Ferris, R. Alcolado, P.J. Winwood, N. Clark, and G. Murphy Tissue inhibitor of metalloproteinase-1 messenger RNA expression is enhanced relative to interstitial collagenase messenger RNA in experimental liver injury and fibrosis Hepatology 24 1 1996 176 184 (Pubitemid 26249431)
75. F.R. Murphy, R. Issa, X. Zhou, S. Ratnarajah, H. Nagase, M.J. Arthur, C. Benyon, and J.P. Iredale Inhibition of apoptosis of activated hepatic stellate cells by tissue inhibitor of metalloproteinase-1 is mediated via effects on matrix metalloproteinase inhibition: Implications for reversibility of liver fibrosis J. Biol. Chem. 277 13 2002 11069 11076 (Pubitemid 34952866)
76. T.M. Leung, M.L. Fung, E.C. Liong, T.Y. Lau, A.A. Nanji, and G.L. Tipoe Role of nitric oxide in the regulation of fibrogenic factors in experimental liver fibrosis in mice Histol. Histopathol. 26 2 2011 201 211
77. M. Roderfeld, R. Weiskirchen, S. Wagner, M.L. Berres, C. Henkel, J. Grotzinger, A.M. Gressner, S. Matern, and E. Roeb Inhibition of hepatic fibrogenesis by matrix metalloproteinase-9 mutants in mice FASEB J. 20 3 2006 444 454 (Pubitemid 44933321)
78. Q. Cao, K.M. Mak, C. Ren, and C.S. Lieber Leptin stimulates tissue inhibitor of metalloproteinase-1 in human hepatic stellate cells: Respective roles of the JAK/STAT and JAK-mediated H2O2-dependant MAPK pathways J. Biol. Chem. 279 6 2004 4292 4304 (Pubitemid 38199017)
79. H. Yoshiji, S. Kuriyama, and H. Fukui Blockade of renin-angiotensin system in antifibrotic therapy J. Gastroenterol. Hepatol. 22 Suppl 1 2007 S93 95
80. V. Serriere-Lanneau, F. Teixeira-Clerc, L. Li, M. Schippers, W. de Wries, B. Julien, J. Tran-Van-Nhieu, S. Manin, K. Poelstra, J. Chun, S. Carpentier, T. Levade, A. Mallat, and S. Lotersztajn The sphingosine 1-phosphate receptor S1P2 triggers hepatic wound healing FASEB J. 21 9 2007 2005 2013 (Pubitemid 47026436)
81. N.J. Torok Recent advances in the pathogenesis and diagnosis of liver fibrosis J. Gastroenterol. 43 5 2008 315 321 (Pubitemid 351958893)
82. Y. Shiratori, F. Imazeki, M. Moriyama, M. Yano, Y. Arakawa, O. Yokosuka, T. Kuroki, S. Nishiguchi, M. Sata, G. Yamada, S. Fujiyama, H. Yoshida, and M. Omata Histologic improvement of fibrosis in patients with hepatitis C who have sustained response to interferon therapy Ann. Intern. Med. 132 7 2000 517 524 (Pubitemid 30171890)
83. D.A. Brenner, and J.M. Alcorn Therapy for hepatic fibrosis Semin. Liver Dis. 10 1 1990 75 83 (Pubitemid 20163708)
84. S. Takase, A. Takada, M. Yasuhara, H. Sato, and Y. Matsuda Effects of malotilate treatment on the serum markers of hepatic fibrogenesis in liver cirrhosis Gastroenterol. Jpn. 23 6 1988 639 645 (Pubitemid 19046847)
85. 4-caused injury and fibrogenesis by attenuating oxidative stress and suppressing inflammation Mol. Pharmacol. 73 2 2008 399 409 (Pubitemid 351159210)
86. J. George, L. Suguna, R. Jayalakshmi, and G. Chandrakasan Efficacy of Silymarin and Curcumin on dimethyl nitrosamine induced liver fibrosis in rats Biomedicine 26 3-4 2006 18 26 (Pubitemid 351578347)
87. Q. Kang, and A. Chen Curcumin suppresses expression of low-density lipoprotein (LDL) receptor, leading to the inhibition of LDL-induced activation of hepatic stellate cells Br. J. Pharmacol. 157 8 2009 1354 1367
88. K. Houglum, A. Venkataramani, K. Lyche, and M. Chojkier A pilot study of the effects of d-alpha-tocopherol on hepatic stellate cell activation in chronic hepatitis C Gastroenterology 113 4 1997 1069 1073 (Pubitemid 27418958)
89. S.I. Aleynik, and C.S. Lieber Polyenylphosphatidylcholine corrects the alcohol-induced hepatic oxidative stress by restoring s-adenosylmethionine Alcohol Alcohol. 38 3 2003 208 212 (Pubitemid 36582565)
90. N. Nieto, and A.I. Cederbaum S-adenosylmethionine blocks collagen I production by preventing transforming growth factor-beta induction of the COL1A2 promoter J. Biol. Chem. 280 35 2005 30963 30974 (Pubitemid 41291829)
91. R. Vercelino, I. Crespo, G.F. de Souza, M.J. Cuevas, M.G. de Oliveira, N.P. Marroni, J. Gonzalez-Gallego, and M.J. Tunon S-nitroso-N-acetylcysteine attenuates liver fibrosis in cirrhotic rats J. Mol. Med. 88 4 2010 401 411
92. M. Pinzani, and K. Rombouts Liver fibrosis: From the bench to clinical targets Dig. Liver. Dis. 36 4 2004 231 242 (Pubitemid 41115470)
93. D.C. Rockey, and J.J. Chung Interferon gamma inhibits lipocyte activation and extracellular matrix mRNA expression during experimental liver injury: Implications for treatment of hepatic fibrosis J. Investig. Med. 42 4 1994 660 670
94. L. Aagaard, and J.J. Rossi RNAi therapeutics: Principles, prospects and challenges Adv. Drug Deliv. Rev. 59 2-3 2007 75 86 (Pubitemid 46770900)
95. K. Cheng, N. Yang, and R.I. Mahato TGF-beta1 gene silencing for treating liver fibrosis Mol. Pharm. 6 3 2009 772 779
96. P.F. Hu, and W.F. Xie Targeted RNA interference for hepatic fibrosis Expert. Opin. Biol. Ther. 9 10 2009 1305 1312
97. J.R. Xia, N.F. Liu, and N.X. Zhu Specific siRNA targeting the receptor for advanced glycation end products inhibits experimental hepatic fibrosis in rats Int. J. Mol. Sci. 9 4 2008 638 661
98. A.S. De Vriese, R.G. Tilton, S. Mortier, and N.H. Lameire Myofibroblast transdifferentiation of mesothelial cells is mediated by RAGE and contributes to peritoneal fibrosis in uraemia Nephrol. Dial. Transplant. 21 9 2006 2549 2555 (Pubitemid 44644530)
99. T.W. Nilsen Mechanisms of microRNA-mediated gene regulation in animal cells Trends Genet. 23 5 2007 243 249 (Pubitemid 46628981)
100. S. Yekta, C.J. Tabin, and D.P. Bartel MicroRNAs in the Hox network: An apparent link to posterior prevalence Nat. Rev. Genet. 9 10 2008 789 796
101. R.S. Pillai, S.N. Bhattacharyya, C.G. Artus, T. Zoller, N. Cougot, E. Basyuk, E. Bertrand, and W. Filipowicz Inhibition of translational initiation by Let-7 MicroRNA in human cells Science 309 5740 2005 1573 1576 (Pubitemid 41266485)
102. C.J. Guo, Q. Pan, T. Cheng, B. Jiang, G.Y. Chen, and D.G. Li Changes in microRNAs associated with hepatic stellate cell activation status identify signaling pathways FEBS J. 276 18 2009 5163 5176
103. S.O. Lee, T. Masyuk, P. Splinter, J.M. Banales, A. Masyuk, A. Stroope, and N. Larusso MicroRNA15a modulates expression of the cell-cycle regulator Cdc25A and affects hepatic cystogenesis in a rat model of polycystic kidney disease J. Clin. Invest. 118 11 2008 3714 3724
104. C. Roderburg, G.W. Urban, K. Bettermann, M. Vucur, H. Zimmermann, S. Schmidt, J. Janssen, C. Koppe, P. Knolle, M. Castoldi, F. Tacke, C. Trautwein, and T. Luedde Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis Hepatology 53 1 2011 209 218